Filter
1953
Filtered Results: 1953
Text search:
trials
guidelines
Featured
Recommendations
210
New Publications
376
Language
Document type
No document type
1060
Guidelines
375
Studies & Reports
301
Manuals
93
Strategic & Response Plan
44
Fact sheets
35
Training Material
23
Situation Updates
8
Infographics
6
Resource Platforms
5
Brochures
2
Videos
1
Countries / Regions
India
107
Global
81
South Africa
54
Kenya
41
Western and Central Europe
33
Africa
28
Nigeria
23
Ethiopia
23
Uganda
22
Sierra Leone
19
Zambia
19
Nepal
17
Tanzania
17
Malawi
17
Eastern Europe
16
Russia
16
Philippines
15
Brazil
15
Latin America and the Carribbean
15
Liberia
14
Ghana
14
Ukraine
14
Zimbabwe
13
Rwanda
13
Indonesia
13
East and Southern Africa
12
Bangladesh
11
West and Central Africa
11
South–East Asia Region
11
Asia
11
Namibia
10
Congo, Democratic Republic of
8
South Sudan
8
Mozambique
8
Lesotho
7
USA
6
Cameroon
6
Germany
6
Syria
6
Eswatini/ Swaziland
6
Colombia
6
Botswana
6
Guinea
5
Senegal
5
Cambodia
5
Thailand
5
Peru
5
Myanmar / Burma
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Burkina Faso
4
Haiti
4
Argentina
4
Albania
4
United Kingdom
4
Guinea-Bissau
3
Lebanon
3
Sudan
3
Angola
3
Georgia
3
Vietnam
3
North America
3
Spain
3
Morocco
2
Pakistan
2
Iraq
2
China
2
Burundi
2
Mexico
2
Sri Lanka
2
Western Pacific Region
2
Paraguay
2
Venezuela
2
Laos
2
Tajikistan
2
Estonia
2
Iran
2
Kyrgyzstan
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Singapore
1
Benin
1
Central African Republic
1
North Macedonia
1
Hungary
1
Ecuador
1
Greece
1
Madagascar
1
Chile
1
Bulgaria
1
Kazakhstan
1
Jamaica
1
Denmark
1
France
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
500
Clinical Guidelines
322
Public Health
152
Women & Child Health
128
Key Resources
41
Pharmacy & Technologies
27
Capacity Building
23
Toolboxes
Mental Health
243
HIV
222
COVID-19
172
TB
167
NCDs
87
AMR
60
NTDs
59
Caregiver
53
Pharmacy
46
Rapid Response
45
Ebola
36
Planetary Health
32
Disability
25
Conflict
21
Refugee
17
Global Health Education
15
Polio
12
Zika
9
Cholera
7
Natural Hazards
6
Specific Hazards
5
Social Ethics
4
Health Financing Toolbox
4
Six months in, the indirect impacts of COVID-19 take a toll on health, social and economic outcomes.
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050.
However, very little is known about the trend of the quality of life over
time in untreated PLWHA compared to treated patients.
Exploring quality of life trends in treated and untreated
patients will help the health care system develop adapted
strategies to better manage the PLWHA in low-income
...
The publication provides an overview and analysis of international instruments that set standards related to the use of antimicrobials across the human, animal and plant sectors, and their release into the environment. The purpose of the document is to identify existing instruments and standards in ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe...
This fourth progress report November 2020 of the Global HIV Prevention Coalition reviews the progress in the 28 focus countries and complements the three previous progress reports. This report describes key developments in 2019–2020, identifies challenges and opportunities (including those associa...
Healthy maternal nutrition, exclusive breastfeeding, and optimal infant and young child nutrition are critical for appropriate growth and development, as well as reducing the risk of developing noncommunicable diseases (NCDs), for both mothers and children. On 7–8 November 2018 the WHO Regional Of...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
The Federal Ministry of Health (FMOH) has been coordinating sector wide reforms that aim to improve equity and quality of health services. It is widely known that; the sector is growing in line the overall growth and transformation plan of the country and the sector is bein...
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
